KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue (Q34509268)

2 August 2017

title

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue (English)

1 reference

2 August 2017

1 reference

18

Stefan Sleijfer

1 reference

2 August 2017

17

John A Foekens

1 reference

2 August 2017

19

John W M Martens

1 reference

2 August 2017

13

Cornelis Verhoef

1 reference

2 August 2017

3

Anieta M Sieuwerts

1 reference

2 August 2017

Bianca Mostert

1

1 reference

2 August 2017

Yuqiu Jiang

2

1 reference

2 August 2017

Haiying Wang

4

1 reference

2 August 2017

Joan Bolt-de Vries

5

1 reference

2 August 2017

Katharina Biermann

6

1 reference

2 August 2017

Jaco Kraan

7

1 reference

2 August 2017

Zarina Lalmahomed

8

1 reference

2 August 2017

Anne van Galen

9

1 reference

2 August 2017

Vanja de Weerd

10

1 reference

2 August 2017

Petra van der Spoel

11

1 reference

2 August 2017

Raquel Ramírez-Moreno

12

1 reference

2 August 2017

Jan N M Ijzermans

14

1 reference

2 August 2017

Yixin Wang

15

1 reference

2 August 2017

Jan-Willem Gratama

16

1 reference

2 August 2017

language of work or name

English

0 references

publication date

9 February 2013

1 reference

International Journal of Cancer

2 August 2017

published in

1 reference

2 August 2017

volume

133

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

130-141

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

2 August 2017

cites work

1 reference

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

21 January 2018

1 reference

Cetuximab for the treatment of colorectal cancer.

21 January 2018

1 reference

Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers.

21 January 2018

1 reference

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

PTEN expression and KRAS mutations on primary tumors and metastases in the prediction of benefit from cetuximab plus irinotecan for patients with metastatic colorectal cancer.

21 January 2018

1 reference

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

21 January 2018

1 reference

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer.

21 January 2018

1 reference

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

21 January 2018

1 reference

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

21 January 2018

1 reference

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

21 January 2018

1 reference

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables

21 January 2018

1 reference

Molecular signature detection of circulating tumor cells using a panel of selected genes.

21 January 2018

1 reference

Mutation detection by real-time PCR: a simple, robust and highly selective method

21 January 2018

1 reference

Oncogenic K-RAS subverts the antiapoptotic role of N-RAS and alters modulation of the N-RAS:gelsolin complex

21 January 2018

1 reference

Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines

21 January 2018

1 reference

Circulating tumor cells and sample size: the more, the better.

21 January 2018

1 reference

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

21 January 2018

1 reference

How ADAM-9 and ADAM-11 differentially from estrogen receptor predict response to tamoxifen treatment in patients with recurrent breast cancer: a retrospective study

21 January 2018

1 reference

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study

21 January 2018

1 reference

Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

21 January 2018

1 reference

Application of COLD-PCR for improved detection of KRAS mutations in clinical samples

21 January 2018

1 reference

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

21 January 2018

1 reference

Comparison of KRAS mutation tests in colorectal cancer patients.

21 January 2018

1 reference

DNA sequencing with chain-terminating inhibitors

21 January 2018

1 reference

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

Multiplex amplification coupled with COLD-PCR and high resolution melting enables identification of low-abundance mutations in cancer samples with low DNA content

21 January 2018

1 reference

Detection of androgen receptor mutations in circulating tumor cells in castration-resistant prostate cancer

21 January 2018

1 reference

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

Circulating tumor cell analysis: technical and statistical considerations for application to the clinic

21 January 2018

1 reference

The patterns and dynamics of genomic instability in metastatic pancreatic cancer

21 January 2018

1 reference

The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases

21 January 2018

1 reference

Heterogeneity of KRAS status may explain the subset of discordant KRAS status between primary and metastatic colorectal cancer.

21 January 2018

1 reference

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

21 January 2018

1 reference

High-throughput droplet digital PCR system for absolute quantitation of DNA copy number

21 January 2018

1 reference

In situ detection and genotyping of individual mRNA molecules

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27987

1 reference

2 August 2017

1 reference